Home Cart Sign in  
Chemical Structure| 59-33-6 Chemical Structure| 59-33-6

Structure of Mepyramine maleate
CAS No.: 59-33-6

Chemical Structure| 59-33-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mepyramine maleate is an antagonist of histamine H1 receptor.

Synonyms: Pyrilamine maleate; Mepyramine (maleate); Pyrilamine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mepyramine maleate

CAS No. :59-33-6
Formula : C21H27N3O5
M.W : 401.46
SMILES Code : CN(C)CCN(CC1=CC=C(OC)C=C1)C2=NC=CC=C2.O=C(O)/C=C\C(O)=O
Synonyms :
Pyrilamine maleate; Mepyramine (maleate); Pyrilamine
MDL No. :MFCD00069333

Safety of Mepyramine maleate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P301+P312+P330-P305+P351+P338

Related Pathways of Mepyramine maleate

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human CCA (Mz-ChA-1) cells 25 μM 6-72 hours To evaluate the effects of H1HR or H2HR antagonists on CCA cell proliferation, invasion, angiogenesis, and EMT. Results showed that H1HR or H2HR antagonist treatment reduced CCA cell proliferation, invasion, and vWF expression, and increased E-Cadherin expression. Hepatology. 2018 Sep;68(3):1042-1056
human hepatic stellate cells 25 μM 6-72 hours To evaluate the expression of H1HR and H2HR and the activation of hHSCs. Results showed that hHSCs express H1HR but minimal H2HR. Treatment with H1HR or H2HR antagonists had no direct effect on hHSC activation. Hepatology. 2018 Sep;68(3):1042-1056

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mdr2−/− mice Primary sclerosing cholangitis (PSC) model Osmotic minipumps 10 mg/kg BW/day Daily for 4 weeks To evaluate the effects of chronic H1HR or H2HR antagonist treatment on PSC-associated damage. Results showed that H1HR or H2HR antagonist treatment reduced liver and biliary damage, fibrosis, and inflammation. Hepatology. 2018 Sep;68(3):1042-1056
Rats Partial sciatic nerve ligation model Intrathecally or intracisternally 200 ng/rat Once daily for 7 days Blocked the effects of histidine on pain behavior and spinal microglia J Neuroinflammation. 2016 Jun 24;13(1):163
Mice Isolated stomach model Bath application 10^-6 to 10^-4 M 15 minutes between each concentration increase In the presence of TTX, mepyramine had no significant effect on the neostigmine-enhanced contraction amplitude but showed a concentration-dependent reduction at higher concentrations (10^-5 to 10^-4 M). Br J Pharmacol. 2022 Mar;179(6):1187-1200

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02601235 Nasal Congestion Phase 3 Recruiting September 2018 Brazil ... More >> Faculdade de Medicina do ABC Recruiting Santo André, SP, Brazil Principal Investigator: Neusa Wandalsen, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.49mL

0.50mL

0.25mL

12.45mL

2.49mL

1.25mL

24.91mL

4.98mL

2.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories